BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 460789)

  • 21. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytocidal action of anticancer antigens: evaluation of the sensitivity of cultured animal and human cancer cells.
    Shimoyama M
    Bibl Haematol; 1975; (40):711-22. PubMed ID: 169835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).
    Fung PY; Longenecker BM
    Cancer Res; 1991 Feb; 51(4):1170-6. PubMed ID: 1825477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Basic principles and clinical pharmacology of cytostatic treatment].
    Schmidt CG
    Verh Dtsch Ges Inn Med; 1980; 86():337-67. PubMed ID: 7223027
    [No Abstract]   [Full Text] [Related]  

  • 25. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
    Heppner GH; Dexter DL; DeNucci T; Miller FR; Calabresi P
    Cancer Res; 1978 Nov; 38(11 Pt 1):3758-63. PubMed ID: 698935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy of solid tumors.
    Alberto P
    Aktuelle Probl Chir; 1970; 14():807-34. PubMed ID: 4147168
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tumor-biology basis of cancer chemotherapy].
    Saul G; Wolf G; Rose H
    Z Arztl Fortbild (Jena); 1981 May; 75(9):404-9. PubMed ID: 7281789
    [No Abstract]   [Full Text] [Related]  

  • 28. Antineoplastic agents and the liver.
    Ménard DB; Gisselbrecht C; Marty M; Reyes F; Dhumeaux D
    Gastroenterology; 1980 Jan; 78(1):142-64. PubMed ID: 7350020
    [No Abstract]   [Full Text] [Related]  

  • 29. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics.
    Tsuruo T
    Cancer Treat Rep; 1983 Oct; 67(10):889-94. PubMed ID: 6354436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A.
    Codington JF; Dalianis T; Miller SC; Das HR; Klein G; Lampert LA; Silber C; Darby DM; Jeanloz RW
    Cancer Res; 1983 Sep; 43(9):4364-72. PubMed ID: 6871869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of vanillin-like compounds on respiration and growth of adenocarcinoma TA3 and its multiresistant variant TA3-MTX-R.
    Cordano G; Pezoa J; Muñoz S; Rivera E; Medina J; Núñez-Vergara LJ; Pavani M; Guerrero A; Ferreira J
    Eur J Pharm Sci; 2002 Sep; 16(4-5):255-63. PubMed ID: 12208455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conceptual basis for use of chemotherapeutic agents and their pharmacology.
    Vietti TJ; Valeriote FA
    Pediatr Clin North Am; 1976 Feb; 23(1):67-92. PubMed ID: 176622
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of medroxyprogesterone acetate and doxorubicin on sublines of 13762 mammary adenocarcinoma in rats.
    Formelli F; Zaccheo T; Casazza AM; Bellini O; Di Marco A
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1211-21. PubMed ID: 6460631
    [No Abstract]   [Full Text] [Related]  

  • 34. Two kinds of antigen suppression in tumor cells revealed by cell fusion.
    Klein G; Friberg S; Harris H
    J Exp Med; 1972 Apr; 135(4):839-49. PubMed ID: 5018053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of first generation transplants of a slow growing solid tumor for the evaluation of new cancer chemotherapeutic agents.
    Sandberg J; Goldin A
    Cancer Chemother Rep; 1971 Jun; 55(3):233-8. PubMed ID: 5115845
    [No Abstract]   [Full Text] [Related]  

  • 36. Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell.
    Miller SC; Codington JF; Klein G
    J Natl Cancer Inst; 1982 Jun; 68(6):981-8. PubMed ID: 6953278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further studies on the relationship between large glycoprotein molecules and allotransplantability in the TA3 tumor of the mouse: studies on segregating TA3-HA hybrids.
    Codington JF; Klein G; Cooper AG; Lee N; Brown MC; Jeanloz RW
    J Natl Cancer Inst; 1978 Apr; 60(4):811-8. PubMed ID: 633390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of D-glucosamine and 6-azauridine on nucleotide contents, 5-fluorouridine uptake, and cytotoxicity in TA3 mammary tumor cells.
    Holstege A; Keppler D
    J Natl Cancer Inst; 1986 Mar; 76(3):485-92. PubMed ID: 2419623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
    Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E
    Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the chemosensitivity of murine tumours in vivo and in cell culture.
    Bullen BR; Russell CW; Giles GR
    Clin Oncol; 1978 Sep; 4(3):265-72. PubMed ID: 750129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.